Dunvegan Associates’s Medtronic MDT Stock Holding History

Dunvegan Associates’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.53M	Sell	19,879 -425	-2%	-$32K	1.8%	15
2015 Q3	$1.36M	Sell	20,304 -327	-2%	-$24.1K	1.55%	21
2015 Q2	$1.53M	Sell	20,631 -3,358	-14%	-$257K	1.69%	18
2015 Q1	$1.87M	Sell	23,989 -510	-2%	-$38.7K	1.66%	19
2014 Q4	$1.77M	Buy	24,499 +23,289	+1,925%	+$1.62M	1.54%	20
2014 Q3	$75K	Hold	1,210	–	–	0.07%	82
2014 Q2	$77K	Hold	1,210	–	–	0.06%	82
2014 Q1	$74K	Buy	+1,210	New	+$70.5K	0.06%	81

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dunvegan Associates's MDT Position: Q4 2015 in Review

Dunvegan Associates reduced its Medtronic (MDT) stake by 2.1% in Q4 2015, selling an estimated $32K and leaving 19,879 shares worth $1.53M. The position accounts for 1.8% of the portfolio, ranked #15.

Dunvegan Associates first reported a position in MDT in Q1 2014 and has held it in 8 quarters since. The position peaked at $1.87M in Q1 2015. 1,252 funds tracked by Wall St. Rank hold MDT as of Q4 2015.

Dunvegan Associates held 19,879 shares of Medtronic worth $1.53M as of Q4 2015.
Dunvegan Associates sold 425 Medtronic shares in Q4 2015, an estimated $32K.
Medtronic made up 1.8% of Dunvegan Associates's portfolio in Q4 2015, its #15 holding.
Dunvegan Associates first reported a position in Medtronic in Q1 2014 and has held it in 8 quarters since.
Dunvegan Associates's Medtronic position peaked at $1.87M in Q1 2015.
1,252 funds tracked by Wall St. Rank held Medtronic as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.